i
Productivity Costs Associated with Metastatic Breast Cancer in Younger, Midlife, and Older Women
-
September 15 2020
-
-
Source: Cancer. 126(18):4118-4125
[PDF-89.37 KB]
Details:
-
Alternative Title:Cancer
-
Personal Author:
-
Description:Background:
The objective of this study was to estimate productivity costs due to metastatic breast cancer (mBC) via productive time lost among survivors and potential life-years lost from premature mortality among three age groups: younger (aged 18-44), midlife (aged 45-64) and older women (aged 65 and older).
Methods:
We estimated the number of work and home productivity days missed due to mBC by age group using 2000-2016 National Health Interview Survey data. Years of potential life lost (YPLL) due to mBC were calculated for each age group using 2015 National Vital Statistics Surveillance System data. We valued both sources of lost productive time using the Current Population Survey and prior studies.
Results:
The per-woman value of lost productive days (work and home) due to mBC ranged from $680 for older women to $5,169 for younger women. The value of lost work and home productivity days associated with mBC nationally was $67 million for younger women, $246 million for midlife women and $66 million for older women in 2015. YPLL was highest among midlife women (403,786 life years), followed by older women (248,522 life years) and younger women (95,943 life years). Midlife women had the highest market value of YPLL ($4.1 billion), followed by younger women ($1.6 billion) and older women ($527 million).
Conclusions:
Our results demonstrate that mBC generates high economic burden through lost productivity, especially among midlife women.
-
Subjects:
-
Source:
-
Pubmed ID:32648979
-
Pubmed Central ID:PMC7721964
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type:
